World's Best Scientists 2026 revealed!
Peter M Andersen

Peter M Andersen

D-Index & Metrics

Genetics

D-Index
82
Citations
22959
World Ranking
1477
National Ranking
17

Medicine

D-Index
90
Citations
26361
World Ranking
12321
National Ranking
234

Overview

Peter M Andersen is affiliated with Umeå University in Sweden and has contributed extensively to the field of medicine, with a primary focus on liver-related diseases and epidemiology. Their research spans multiple interconnected subfields, including epidemiology, hepatology, pathology and forensic medicine, endocrinology, diabetes and metabolism, and physiology.

Andersen's work covers a range of topics centered on liver disease diagnosis and treatment, alcohol consumption and its health effects, liver disease and transplantation, diet and metabolism studies, and signaling pathways such as sphingolipid metabolism. They have notably contributed to research in hepatitis C virus.

Frequent coauthors in Andersen's publications include:

  • Aleksander Krag
  • Maja Thiele
  • Katrine Prier Lindvig
  • Mads Israelsen
  • Stine Johansen

Their published work appears predominantly in journals such as:

  • Journal of Hepatology
  • The Lancet. Gastroenterology & Hepatology
  • Clinical Gastroenterology and Hepatology
  • Gastroenterology
  • JHEP Reports

Notable recent papers authored or coauthored by Andersen include:

  • Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease (2023, Journal of Hepatology)
  • Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study (2023, The Lancet)
  • Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study (2024, The Lancet. Gastroenterology & Hepatology)
  • Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease (2022, Annals of Internal Medicine)
  • Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial (2023, The Lancet. Gastroenterology & Hepatology)

Best Publications

  • EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) : revised report of an EFNS task force

    Peter M. Andersen;Sharon Abrahams;Gian D. Borasio;Mamede de Carvalho

  • VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death

    Diether Lambrechts;Erik Storkebaum;Masafumi Morimoto;Jurgen Del-Favero

  • Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

    Aude Nicolas;Kevin P. Kenna;Alan E. Renton;Alan E. Renton;Nicola Ticozzi

  • Toxicity of Familial ALS-Linked SOD1 Mutants from Selective Recruitment to Spinal Mitochondria

    Jian Liu;Concepción Lillo;P.Andreas Jonsson;Christine Vande Velde

  • Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

    Wouter van Rheenen;Aleksey Shatunov;Annelot M. Dekker;Russell L. McLaughlin

  • Deletions of the Heavy Neurofilament Subunit Tail in Amyotrophic Lateral Sclerosis

    Ammar Al-Chalabi;Peter M. Andersen;Peter Nilsson;Barry Chioza

  • Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis.

    Michael A van Es;Jan H Veldink;Christiaan G J Saris;Hylke M Blauw

  • A yeast functional screen predicts new candidate ALS disease genes

    Julien Couthouis;Michael P. Hart;James Shorter;Mariely DeJesus-Hernandez

  • Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

    Timothy Miller;Merit Cudkowicz;Pamela J. Shaw;Peter M. Andersen

  • Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase.

    Peter M. Andersen;Peter Nilsson;Veli Ala-Hurula;Marja-Leena Keränen

  • Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia.

    P M Andersen;P Nilsson;M L Keränen;L Forsgren

  • EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives

    Peter M. Andersen;G. D. Borasio;R. Dengler;O. Hardiman

  • Novel Antibodies Reveal Inclusions Containing Non-Native SOD1 in Sporadic ALS Patients

    Karin Forsberg;P. Andreas Jonsson;Peter M. Andersen;Daniel Bergemalm

  • EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans

    Annelies Van Hoecke;Lies Schoonaert;Robin Lemmens;Mieke Timmers

  • Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients

    Petra Steinacker;Emily Feneberg;Jochen Weishaupt;Johannes Brettschneider

  • ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics

    Olubunmi Abel;John F Powell;Peter M. Andersen;Peter M. Andersen;Ammar Al-Chalabi

  • Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models

    P. Andreas Jonsson;Karin S. Graffmo;Peter M. Andersen;Thomas Brännström

  • Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants

    Mikael J Lindberg;Roberth Byström;Niklas Boknäs;Peter Munch Andersen

  • An enteric helminth infection protects against an allergic response to dietary antigen.

    Mohamed Elfatih H. Bashir;Peter Andersen;Ivan J. Fuss;Hai Ning Shi

  • Genome-Wide Analyses Identify KIF5A as a Novel ALS Gene

    Aude Nicolas;Kevin P. Kenna;Alan E. Renton;Nicola Ticozzi

Frequent Co-Authors

Stefan L. Marklund
Stefan L. Marklund Umeå University
Albert C. Ludolph
Albert C. Ludolph University of Ulm
Ammar Al-Chalabi
Ammar Al-Chalabi King's College London
Orla Hardiman
Orla Hardiman Trinity College Dublin
Christopher Shaw
Christopher Shaw King's College London
Jan H. Veldink
Jan H. Veldink Utrecht University
John Landers
John Landers University of Massachusetts Chan Medical School
Leonard H. van den Berg
Leonard H. van den Berg Utrecht University
Mamede de Carvalho
Mamede de Carvalho University of Lisbon

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Genetics in the USA opens doors to a range of science and healthcare careers. If you're considering related paths, there are diverse online programs that can help build your skills and expertise.

For those interested in the administrative side of healthcare, a healthcare administration degree can be valuable. Many students prefer the flexibility of a healthcare administration degree online, which allows you to balance your studies with work or personal commitments.

If you're looking for a clinical path, the easiest nursing program to get into may offer a practical route into patient care—an essential role in genetics research and healthcare delivery. Those interested in integrating technology and healthcare can explore medical billing and coding online courses, which are vital for maintaining accurate health records.

Each of these pathways provides opportunities for growth and can complement a genetics background, opening new doors in a rapidly evolving job market.

Best Scientists Citing Peter M Andersen

Trending Scientists